EdwardGreenbergMD

Summary

• Developing novel innovative therapeutics for patients with neurodegenerative disorders (e.g. Alzheimer's disease, Parkinson's disease) and psychiatric disorders (e.g. bipolar disorder, depression/anxiety). Specializes in understanding and therapeutically-modulating age-related diseases. Board-certified hematologist-oncologist with a focus in hematologic malignancies. Decades of translational and clinical research experience. 14 peer-reviewed publications, multiple national presentations and awards. Skilled in early-phase clinical trial design, tissue culture, immunofluorescence, western blotting, immunoprecipitation, flow cytometry, cellular viability, calcium signaling, cytoblotting, enzyme kinetics, statistical modeling, RNAi.